Research Notes

Stay informed with the most recent market and company research insights.

A man sitting at a table with a glass of orange juice.

Research Notes

Health Insurance business the standout.

Medibank
3:27pm
February 28, 2025
MPL’s 1H25 Underlying NPAT (A$298m) was 6% above company compiled consensus (A$282m). This was a strong MPL result overall, highlighted by a robust performance in its key Health Insurance franchise. We upgrade our MPL FY25F/FY26F operating profit forecasts by 3%-4%, with more muted changes at EPS (-1%/+1%). Our MPL price target is raised to A$4.52 (previously A$4.11) on our earnings changes and a valuation roll-forward. Whilst this was a good result, we see MPL trading on 19x PE as fair value at current levels. HOLD.

Accelerating flows sees earnings growth continue

Regal Partners
3:27pm
February 28, 2025
Given Dec-24 FUM and CY24 performance fees were pre-released, the result was largely in line with expectations. That aside, it is not lost on us the scale to which this business has grown over the past 12 months - normalised NPAT +200% (vs pcp), FUM +64% (+25% excluding Merricks and Argyle acquisitions), dividends up 180%. Momentum in net inflows (+$1.9bn or +310% on pcp) will likely see continued growth in both base management fees and performance fees (96% of net flows performance fee-eligible), while the 30% of flows from offshore investors extends the reach of RPL’s distribution and FUM aspirations. Trading at a PER of 14x (CY24), with a strong balance sheet and capacity to continue growing FUM, we retain our Add rating with a price target of $4.50/sh (previously $4.40/sh).

1H25 earnings: Making a strong point

BETR Entertainment
3:27pm
February 28, 2025
BBT has maintained strong performance over the past six months, benefiting from a successful Spring Racing Period and the migration of betr customers onto its platform. The company delivered positive EBITDA of $1.7m and remains on track to achieve an EBITDA-positive result for the full year. BBT expressed disappointment over PBH’s Board rejecting its initial cash and scrip offer in favor of MIXI’s all-cash deal. BBT says it plans to release further details on its value proposition in the coming days, which based on limited data available we believe could be in excess of 70% EPS accretive. We have not included any deal in our numbers. Following the result, our FY26 EBITDA estimate decreases nominally to $5.8m. We retain an Add rating, with our $0.47 price target unchanged.

Marketing set to ramp up in the second half

Airtasker
3:27pm
February 28, 2025
Airtasker’s (ART) 1H25 result was largely pre-released, and the majority of key headline metrics known. The operating performance was broadly per our expectations, with growth seen across all regions. A ramp up in media inventory deployment in the 2H (for the northern hemisphere peak) should assist in its offshore marketplaces maintaining its robust growth momentum. Our revenue forecasts are largely unchanged, and we make only marginal changes to our marketing expense assumptions in this note given management guidance. Our price target remains unchanged at A$0.56. Add maintained.

The elephant in the room

Clinuvel Pharmaceuticals
3:27pm
February 27, 2025
CUV has reported its 1H25 result which lands in-line with consensus and our forecasts on revenues, but ahead in NPAT however the beat was driven by a surprise wind-down of material costs to practically zero. A low-quality beat here and we would expect there to be a true-up over the coming halves. The elephant in the room continues to grow, and management opts to defy investor concerns around its lazy balance sheet, with cash now sitting ~33% of the market valuation. We downgrade our target price to A$15 p/s (from A$17 p/s) and we move the recommendation to a Speculative Buy, noting increased risk around competitive threats. Traders may find an opportunity down here, but equally prepared to wait until several investor concerns are addressed and external threats unfold.

Post balance pick up

Objective Corporation
3:27pm
February 27, 2025
OCL’s 1H25 result, was broadly in-line with our forecasts with NPAT of $17.0m consistent with MorgF, however ARR growth of 10% in 1H25 was softer than MorgF (13%) however this appears to have been made up with a further $4.5m of wins over the last 2 month, 1H25 EBITDA margins were also better than feared, however previously flagged investment in US sales is expected to land in 2H25, which will likely see FY25 margins consistent with 39% in 1H25. Management reiterated confidence in its 15% Net ARR growth target, pointing to building momentum across each of its business line into 2H25 (vs to MorgF 13.3%). We reduce our EBITDA forecasts by -2% across FY25-FY27F, this sees our blended DCF/EV/EBITDA based price target revised to $16.75ps (from $17.80ps), our Hold rating is retained.

2H24: Minimal surprises

Atlas Arteria
3:27pm
February 27, 2025
Toll revenue had already been released, so a key forecast risk was already known. Asset EBITDA was broadly as expected. ALX’s updated DPS guidance and policy supports our 40 cps DPS forecast over coming years. Implied cash yield at current prices is 7.7%, albeit DPS growth may be limited. Forecast changes are minimal, except for updating for the revised FE debt amortisation profile. BAU valuation/target price decrease 2 cps to $4.31/$4.60.

Picks up a bargain?

Karoon Energy
3:27pm
February 27, 2025
A strong set of CY24 numbers, helped by a material cash tax saving, KAR also announced it had struck a deal buying Bauna’s FPSO for a good-looking price. KAR estimates the ~US$115m acquisition has IRR of >20% and ~4 year payback. Management is focused on its existing portfolio, with no M&A plans. Bumper A9.496 cent dividend (6.5% yield), and US$85.7m share buyback. Maintain ADD rating with an upgraded A$2.45 target price (was A$2.20).

Cruising past the industry margin pressures

Eagers Automotive
3:27pm
February 27, 2025
APE delivered FY24 PBT of A$371m (-14% on pcp), a strong outcome in the context of broad industry pressures and severely weak peer results. ROS margin was held stable in 2H24 at ~3.3% (vs industry average ~1.2%). APE pointed to stable to improving near-term margin, with uplift expected medium-term. APE guided to ~A$1bn top-line growth (A$1.3bn delivered FY24), underpinned by completed acquisitions and organic growth in EA123 and the Retail JV. Near-term, visible top-line growth and a persistent focus on margin provides earnings resilience and a solid growth outlook. Long-term, we expect APE to continue to prove that the groups scale extends its competitive advantage, and along with industry change increases the growth avenues. Add maintained.

Industrial Access was the star performer

Acrow
3:27pm
February 27, 2025
ACF’s 1H25 result was in line with our expectations and management’s guidance provided in November. The result was driven by strong growth in Industrial Access, partly offset by lower contributions from Formwork and Commercial Scaffold. Management has maintained FY25 revenue and EBITDA guidance in addition to providing underlying NPAT and underlying EPS targets. We make no changes to FY25F EBITDA but lift FY26F and FY27F EBITDA marginally (by 1-2%). Our target price rises slightly to $1.32 (from $1.30). In our view, ACF’s increasingly diversified business that includes screens, jumpform, industrial access and formwork in addition to ongoing new product development provides multiple growth levers in an operating environment that remains healthy. Trading on 8.6x FY26F PE and 5.7% yield, we believe the long-term investment proposition remains attractive and maintain our Add rating.

News & Insights

The US economy is growing strongly at 2.34% in Q2 2025 but is expected to slow to 1.4% in 2025, with falling interest rates and a weaker US dollar likely to boost commodity prices, benefiting Australian markets. Michael Knox discusses.

We think the US economy is currently experiencing solid growth, with data from the Chicago Fed  National Activity Index indicating an annual growth rate of just above  2%. This aligns with projections from other parts of the Federal Reserve System, such as the New York Fed. The New York Fed’s weekly Nowcast, updated every Friday, estimates that for the second quarter of 2025, the US economy is growing at an annualised rate of 2.34%, surpassing the 2% mark. This robust growth is consistent with our model’s view that the US economy is now performing strongly. However, we anticipate a slowdown in the second half of 2025.

On 18 June the Fed released its Summary of Economic Projections  with the Federal Reserve’s  forecasting US GDP growth to drop to 1.4% in 2025, down from their March estimate of 1.7%. Looking further ahead, growth is expected to pick up slightly to 1.6% in 2026 and 1.8% in 2027, aligning with the long-term trend growth rate of around 1.8%. We believe this recovery trend could be even  higher,  driven by reduced regulation under the second Trump administration and aggressive tax write-offs for companies building factories in the US, allowing 100% write-offs for equipment and buildings in the first year. This policy should foster stronger systemic growth.

Economic Projections of the Federal Reserve

The Fed expects that as the economy slows,  unemployment is projected to rise to 4.5% from the current level of 4.2%. Inflation, measured by the Consumer Price Index (CPI), is running at 3.5% this year, approximately 50 basis points higher than the Personal Consumption Expenditures (PCE) index of 3.0%, with 1.6% of this  inflation  attributed to tariffs. The Fed expects PCE Inflation  to ease to 2.4% in 2026 and 2.1% in 2027. The Federal Reserve anticipates cutting the effective  federal funds rate, currently at 433 basis points (according to the New York Fed), by 50 basis points by the end of 2025, followed by an additional 25 basis points in each of the next two years. This aligns with our own Fed Funds rate  model’s current equilibrium federal funds rate of  3.85% . The Fed Outlook  supports our scenario of a slowing US economy and rate cuts in the second half of 2025 and beyond. A falling US dollar is then expected to exert upward pressure on commodity prices, benefiting Australian Equity markets.

Taking questions during the Press Conference after releasing the Fed statement  ,Federal Reserve Chair Jay Powell,   addressed the certainty and uncertainty surrounding the inflationary effects of tariffs. Initially, at the start of 2025, the inflationary impact of tariff policies was unclear, but three months of favourable inflation data have provided this clarity, indicating that the inflationary effects are less severe than anticipated. Powell noted that the Feds own uncertainty on the inflationary effects of  tariffs  peaked in April 2025, and the Federal Reserve now has a clearer understanding that  the inflation effects, are lower than initially expected.

The Fed view  supports our own scenario of a slowing US economy in the second half of 2025, allowing for Fed rate cuts  . This in turn should then lead to  a falling US dollar, which we in turn  expect to drive rising commodity prices.

Read more
The Your Wealth publication is our half yearly scrutiny into current affairs for wealth management. Our latest Issue 29 is out now.

The second half of 2025 will be an interesting time for everyone. Geopolitical uncertainty prevails. How will all of this impact the Australian investor and in particular, their wealth and retirement savings? Whether you are an accumulator, saving for short- and long-term goals, or a retiree, hoping for a comfortable retirement, the ability to manage this uncertainty will be key.

When we published the previous Your Wealth – First Half 2025, the Division 296 Bill (Div296) was also facing uncertainty. The Bill was eventually blocked in the Senate prior to the Federal Election. The Labor Party succeeded in winning so it’s Ground Hog Day for Div296. The Government doesn’t have the numbers in the Senate to pass the Bill without support from other parties. The Greens are the likely negotiating party but will undoubtably have their own agenda. Regardless, there is a high probability this legislation will be passed once Parliament resumes.

Our message to our clients is to wait until we know more details and to not act in haste.

In addition to our Feature Article which provides further insights on Div296, this edition also Spotlights the Aged Care changes due this year, with the start date pushed back to 1 November.

We hope readers enjoy this edition of Your Wealth.


Morgans clients receive exclusive insights such as access to our latest Your Wealth publication. Contact us today to begin your journey with Morgans.

      
Contact us
      
Read more
Michael Knox, Chief Economist, reveals how the OECD and RBA’s outdated assumptions about global trade fail to account for China’s Marxist-Leninist economic strategies.

This morning, I was asked to discuss Sarah Hunter’s presentation from yesterday. Sarah, the Assistant Governor and Chief Economist at the Reserve Bank of Australia (RBA), delivered a detailed and competent discussion on the conventional view of tariffs’ impact on the international economy. She highlighted that tariffs typically increase inflation and reduce economic output, a perspective echoed by the OECD in a similar presentation overnight. Sarah’s analysis focused on the potential shocks tariffs could cause, particularly their effects on GDP and inflation.

Drawing on my experience as an Australian trade commissioner and my work in Australian embassies, I found her presentation particularly interesting. My background allowed me to bring specialist knowledge to the conversation, which I believe gave me an edge. Notably, I observed that the RBA seems to lack analysts closely tracking individual policymakers in the Trump administration, such as Scott Bessent, whose views on tariffs and competition differ from the general assumptions. The conventional view assumes a world of perfectly competitive countries adhering to international trade rules and unlikely to engage in conflict—a scenario that doesn’t align with the current global trade environment, especially between China and the United States.

China, operating as a Marxist-Leninist economy, aims to dominate global markets by building monopolies in areas like rare earths, nickel, copper, and other base metals. It maintains a managed exchange rate, despite promises to the International Monetary Fund for a freely floating currency. If China allowed its currency, the RMB, to float, it would likely appreciate significantly, increasing imports and reducing its trade surplus. This would create a more balanced international trade environment, potentially reducing the need for other countries to impose tariffs. However, major institutions like the OECD and RBA seem to misjudge the nature of this trade shock, relying on outdated assumptions about global trade dynamics.

The international community also appears to overlook specific U.S. policy intentions, such as those articulated by figures like Peter Navarro and Scott Bessent. The U.S. aims to use tariffs selectively to bolster industries like pharmaceuticals, precision manufacturing, and motor vehicles. This misunderstanding leads public institutions to perceive unspecified risks, as reflected in Sarah’s otherwise able presentation. Because the RBA and similar institutions view the world as fraught with undefined risks, they are inclined to keep interest rates low, responding to perceived threats rather than an equilibrium model.

Interestingly, data from the U.S. economy contradicts the expected negative impacts of tariffs. The Chicago Fed National Activity Indicator, a reliable gauge of economic growth since the 2008 financial crisis, shows U.S. growth above the long-term trend for the first four months of this year. This suggests resilience despite tariff-related shocks. Ideally, growth will slow later this year, prompting the Federal Reserve to cut rates, facilitating a soft landing and a decline in the U.S. dollar to boost global commodity prices. However, this nuanced outlook wasn’t evident in yesterday’s presentation.

Moreover, the anticipated rise in U.S. inflation due to tariffs isn’t materialising. Scott Bessent recently noted that U.S. CPI inflation is lower than expected, with core inflation shown as the (16% trimmed mean) at 3% for the past two months . Core inflation  excluding  food and energy CPI  is only at 2.8%. This suggests that Chinese suppliers are absorbing tariff costs to maintain market share, rather than passing them on as higher prices. Recent Chinese data supports this, showing a slight decline in manufacturing confidence and coal consumption, indicating reduced factory output and electricity use. This points to a modest slowdown in China’s economy. So far the expected negative effects on U.S. prices and output are not occurring.

In summary, the fears expressed by institutions like the RBA and OECD about the Trump administration’s trade policies appear overstated. The U.S. economy is not experiencing the predicted declines in output or increases in inflation. While these effects may emerge later, the current data suggests that the risks are not as severe as anticipated, highlighting a disconnect between theoretical models and real-world outcomes.

Read more